Paul Cook

机构：East Carolina University

发表论文 122 篇 · 总被引 4252 次 · h-index 30

代表论文

• Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study (2024 · The Lancet HIV · 被引 47)
• Dalbavancin for Treatment of Staphylococcus aureus Bacteremia (2025 · JAMA · 被引 42)
• MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens (2023 · Biology · 被引 37)
• Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials (2023 · The Lancet HIV · 被引 34)
• Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model (2022 · Drug Delivery and Translational Research · 被引 10)
• Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab (2025 · The Journal of Infectious Diseases · 被引 8)